Therefore, we conducted this study to explore the status of KRAS, DDR2, and TP53 genes in hotspot regions on a panel of lung cancer samples including three major NSCLC subtypes (ADC, SCC, and LCC) and SCLC in the Iranian population. The gene discussed is TP53; the disease is lung carcinoma.